Planet 13 Holdings (PLNH) Cash from Financing Activities (2021 - 2025)

Planet 13 Holdings' (PLNH) quarterly Cash from Financing Activities came in at $1.8 million in Q2 2025, up 150.55% year-on-year from $698465.9 in Q2 2024, and up 3241.74% on a QoQ basis from $52368.0 in Q1 2025.

Planet 13 Holdings (PLNH) Cash from Financing Activities (2021 - 2025) Analysis & Trends

Planet 13 Holdings (PLNH) has 5 years of Cash from Financing Activities data on file, last reported at $1.8 million in Q2 2025.

  • On a quarterly basis, Cash from Financing Activities rose 150.55% year-over-year to $1.8 million in Q2 2025; TTM through Mar 2026 was $1.8 million, a 155.85% increase from a year earlier, with the FY2025 full-year figure at $1.8 million, down 73.21% from the prior year.
  • Cash from Financing Activities for Q2 2025 stood at $1.8 million, up from $52368.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for PLNH reached as high as $61.2 million in Q1 2021 and fell as low as -$3.5 million in Q2 2024.
  • Historically, Cash from Financing Activities has averaged $5.3 million across 5 years, with a median of $75174.0 in 2022.
  • Across the five-year window, Cash from Financing Activities soared 5929.2% in 2022 and sank 1527700.0% in 2024, its largest moves.
  • Year by year, Cash from Financing Activities stood at $17320.0 in 2021, then surged by 5929.2% to $1.0 million in 2022, then tumbled by 100.0% to -$3.0 in 2023, then sank by 1527700.0% to -$45834.0 in 2024, then soared by 3918.13% to $1.8 million in 2025.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were $1.8 million in Q2 2025, $52368.0 in Q1 2025, and -$45834.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -840.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -494.13 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1.48 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -203.80 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -86.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -65.00 Mn
10 Planet 13 Holdings 39.35 Mn 23.09 Mn 9.41 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 1.75 Mn
Jun 30, 2025 1.75 Mn
Mar 31, 2025 52,368.00
Mar 31, 2025 52,368.00
Dec 31, 2024 -45,834.00
Dec 31, 2024 -45,834.00
Sep 30, 2024 322,049.00
Sep 30, 2024 322,049.00
Jun 30, 2024 -3.46 Mn
Jun 30, 2024 -3.46 Mn
Mar 31, 2024 9.91 Mn
Mar 31, 2024 9.91 Mn
Dec 31, 2023 -3.00
Dec 31, 2023 -3.00
Jun 30, 2023 -267,526.00
Jun 30, 2023 -267,526.00
Dec 31, 2022 1.04 Mn
Dec 31, 2022 1.04 Mn
Jun 30, 2022 97,980.00
Jun 30, 2022 97,980.00